Abstract
COVID-19, caused by the novel coronavirus strain SARS-CoV-2 that emerged in late 2019, has resulted in a global pandemic. COVID-19 was initially believed to occur less frequently in children with relatively mild disease. However, severe disease and varied presentations have been reported in infected children, one of such being intussusception. There have only been three reported cases of intussusception in the pediatric population infected with COVID-19. In this paper, we will discuss the management and treatment of a novel fourth case of COVID-19-associated intussusception. This case is the first reported in the USA and suggests that COVID-19 may be implicated in the development of intussusception. Pediatricians should consider the possibility of intussusception when a child with COVID-19 presents with abdominal pain.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus first appeared in late 2019 and is responsible for the global coronavirus 2019 (COVID-19) pandemic. Unlike in the adult population where respiratory symptoms are characteristic, few infected children are symptomatic with only about half presenting with fever or cough. Additionally, gastrointestinal (GI) symptoms have been documented to occur more commonly in children than in adults. Intussusception is a possible but rare GI manifestation of COVID-19 infection with only three other reported cases worldwide [1,2,3], making this case the first of its kind to be reported in the USA.
Case presentation
A 9-month-old Hispanic male initially presented to the outpatient clinic on June 27, 2020, with complaints of increased fussiness, congestion, cough, and sneezing for 4 days and fever of 100.7 °F (38.2 o C) for 1 day. The patient’s contact history was positive for similar symptoms in close relatives. SARS-CoV-2 polymerase chain reaction (PCR) molecular testing was performed which yielded a positive result.
Two days following the initial outpatient visit, the patient presented to the emergency room with complaints of vomiting, episodic abdominal pain, decreased oral intake, and blood streaked stool. Signs of dehydration were noted on physical examination, but the abdominal exam was unremarkable. Urinalysis revealed ketonuria (80 mg/dl) and proteinuria (30 mg/dl). Complete blood count was significant for decreased lymphocytes at 1.6 × 103 μl. Abdominal radiograph (AXR) and abdominal ultrasound confirmed the presence of ileocolic intussusception (Fig. 1).
Non-surgical management with fluoroscopy-guided hydrostatic reduction of the intussusception was performed using a solution of saline and Gastrografin® (diatrizoate meglumine and diatrizoate sodium solution) contrast material. Successful reduction was achieved in a single attempt without complications (Fig. 2). The patient remained stable and was discharged home the following day.
Discussion
COVID-19 refers to the infection caused by the novel 2019 coronavirus strain, SARS-CoV-2, that emerged in late 2019 and has been subsequently declared a global pandemic by the World Health Organization (WHO) on March 2, 2020. As of July 11, 2020, the virus has resulted in more than 12 million infections and over half a million deaths worldwide. The USA accounts for a quarter of these infections with more than 3 million cases and over 130,000 deaths [4]. Initially, COVID-19 was believed to be less frequent and not as virulent in children. However, reports from Europe and the USA have emerged depicting an association between COVID-19 infection in children and a condition called multisystem inflammatory syndrome in children (MIS-C) [5]. The Center for Disease Control’s (CDC) case definition of this syndrome is outlined in Table 1.
Intussusception is the most common abdominal emergency in young children [6] and the most common cause of intestinal obstruction in children between 3 months and 6 years [7] . There have been three reported cases of intussusception associated with COVID-19 worldwide [1,2,3] with ours being the fourth case and the first in the USA. A comparison of our case with the other documented cases is included in Table 2. Most pediatric intussusceptions are idiopathic with a precipitating lesion detected in only about 10–25% of cases [6, 8]. Nonetheless, several factors have been implicated in its pathophysiology. Viral infections are the most prevalent etiologic factor [9] with the most commonly implicated virus being non-enteric adenoviruses [9]. In the limited cases with identifiable lead points, lymphoid hyperplasia of Peyer’s Patches within the ileum was the most common instigating lead point [8]. Although the pathogenesis of COVID-19- related intussusception is not fully understood, it can be inferred to parallel the other viral associated intussusception cases. This involves an alteration in the peristaltic movement of the bowel wall which enables the telescoping of adjacent loops of bowel into each other, manifesting as intussusception [6]. Notably, the widespread immune activation that has been shown to be prevalent in COVID-19 may result in hypertrophy of the intestinal Peyer’s patches thereby inciting intussusception.
Of the four reported cases of COVID-19-related intussusception, there has been one mortality. This contrasts with the mortality rate of less than 1% in intussusception associated with other viruses. The heightened mortality in COVID-19-associated intussusception is dependent on the association with MIS-C as seen in the case in Wuhan, China [2] who developed multiple organ failure and eventually died. Hence, prompt testing, institution of appropriate precautions, and preparation for possible complications are of vital importance in patients with COVID-19-related intussusception. Our case, however, did not meet the diagnostic criteria for MIS-C as outlined in Table 1.
The gold standard for management of intussusception in children is non-surgical reduction by hydrostatic or pneumatic enema under fluoroscopic or sonographic guidance with surgery reserved for complicated cases or after failure of non-surgical reduction. All reported cases of COVID-19-associated intussusception had successful non-surgical reduction, even the patient who eventually died. Hence, enema reduction should be attempted in uncomplicated cases of COVID-19-associated intussusception, as prescribed by current guidelines.
Conclusion
Our case report suggests that COVID-19 may be implicated in the development of intussusception. Hence, it is important that pediatricians consider the possibility of intussusception when a COVID-19 patient presents with abdominal pain. Also, as children infected with SARS-CoV-2 are more likely to be asymptomatic or exhibit non-respiratory symptoms, we propose that children with intussusception during this pandemic should be tested for SARS-CoV-2. This is imperative as timely diagnosis is crucial for the successful management of COVID-19 and avoidance of potentially severe complications, including MIS-C.
Abbreviations
- SARS-CoV-2:
-
Severe acute respiratory syndrome coronavirus 2
- COVID-19:
-
Coronavirus 2019
- GI:
-
Gastrointestinal
- PCR:
-
Polymerase chain reaction
- AXR:
-
Abdominal radiograph
- WHO:
-
World Health Organization
- MIS-C:
-
Multisystem inflammatory syndrome in children
- CDC:
-
Centers for Disease Control
- Tmax:
-
Maximum temperature
References
Moazzam Z, Salim A, Ashraf A, Jehan F, Arshad M (2020) Intussusception in an infant as a manifestation of COVID-19. J Pediatr Surg Case Rep 59:101533–101533. https://doi.org/10.1016/j.epsc.2020.101533
Cai X, Ma Y, Li S, Chen Y, Rong Z, Li W (2020) Clinical characteristics of 5 COVID-19 cases with non-respiratory symptoms as the first manifestation in children. Front Pediatr 8:258. https://doi.org/10.3389/fped.2020.00258
Martínez-Castaño I, Calabuig-Barbero E, Gonzálvez-Piñera J, López-Ayala JM (2020) COVID-19 infection is a diagnostic challenge in infants with ileocecal intussusception. Pediatr Emerg Care 6:e368
CDC. Coronavirus disease 2019 (COVID-19) cases and deaths in the US. Accessed July 11th, 2020, https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/us-cases-deaths.html
CDC. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). https://emergency.cdc.gov/han/2020/han00432.asp
Cera SM (2008) Intestinal intussusception. Clin Colon Rectal Surg 21(2):106–113. https://doi.org/10.1055/s-2008-1075859
Waseem M, Rosenberg HK (2008) Intussusception. Pediatr Emerg Care 24(11):793–800. https://doi.org/10.1097/PEC.0b013e31818c2a3e
Ntoulia A, Tharakan SJ, Reid JR, Mahboubi S (2016) Failed intussusception reduction in children: correlation between radiologic, surgical, and pathologic findings. AJR Am J Roentgenol 207(2):424–433. https://doi.org/10.2214/ajr.15.15659
Okimoto S, Hyodo S, Yamamoto M, Nakamura K, Kobayashi M (2011) Association of viral isolates from stool samples with intussusception in children. Int J Infect Dis 15(9):e641–e645. https://doi.org/10.1016/j.ijid.2011.05.008
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bazuaye-Ekwuyasi, E.A., Camacho, A.C., Saenz Rios, F. et al. Intussusception in a child with COVID-19 in the USA. Emerg Radiol 27, 761–764 (2020). https://doi.org/10.1007/s10140-020-01860-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10140-020-01860-8